免疫系统
免疫学
抗体
免疫
人类免疫缺陷病毒(HIV)
病毒学
抗体依赖性细胞介导的细胞毒性
获得性免疫系统
生物
效应器
体液免疫
猿猴免疫缺陷病毒
单克隆抗体
作者
Mar Naranjo-Gómez,Mireia Pelegrín
出处
期刊:Current Opinion in Hiv and Aids
[Ovid Technologies (Wolters Kluwer)]
日期:2019-07-01
卷期号:14 (4): 325-333
被引量:13
标识
DOI:10.1097/coh.0000000000000555
摘要
Purpose of review The review recalls recent findings regarding the induction of vaccinal effects by HIV-1 broadly neutralizing antibodies (bNAbs) and highlights potential therapeutic strategies to exploit such immunomodulatory properties. Recent findings Studies in different animal models have shown that mAbs can generate long-lasting protective immunity. Induction of this vaccinal effect by HIV-1 bNAbs has also been more recently reported in animal models of HIV-1 infection. Notably, bNAbs treatment of macaques infected with the chimeric simian-human immunodeficiency virus (SHIV) improved both humoral and cellular adaptive immune responses that contributed to disease control. Importantly, this concept has been extended to HIV-1-infected patients as enhancement of humoral responses was recently reported in HIV-1 patients treated with bNAbs. Studies aiming at elucidating the mechanisms underlying these immunomodulatory properties of bNAbs have identified a role for immune complexes in shaping immune responses against HIV-1. They also highlight different Fc (fragment crystallizable) region effector functions that might be required for the enhancement of HIV-1 immune responses upon bNAbs treatment. Summary HIV-1 bNAbs can elicit protective adaptive immune responses through mechanisms involving multiple cellular and molecular actors of the immune system. Harnessing these mechanisms will be crucial to achieve protective immunity against HIV-1 infection by bNAbs.
科研通智能强力驱动
Strongly Powered by AbleSci AI